Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea
the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.
- EligibilityCriteria: Inclusion Criteria  Meeting the diagnostic criteria of mild to moderate erythema telangiectasis rosette acne; more than 18 years old; to obey the rules of the treatment in the study, and can be followed up for 12 weeks; informed consent;  Exclusion Criteria:  Had received facial cosmetic surgery or botulinum toxin treatment within 6 months before this treatment; due to systemic diseases such as autoimmune diseases or menopause facial flush; had allergies botulinum toxin; pregnant or breastfeeding; other facial skin or oral disease therapy, including research before 4 weeks rose acne accept other treatment; With basic neuromuscular diseases (such as myasthenia gravis, amyotrophic lateral sclerosis, etc.); All landowners 4 weeks before the study whether any oral aminoglycoside drugs, benzodiazepines drugs or muscle relaxants; .Was removed during treatment observation data is not complete, incomplete treatment and patients can't take medication as prescribed. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 60 Years - StdAgeList: Adult